首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Comparative genomics of Neisseria meningitidis strains: new targets for molecular diagnostics
【24h】

Comparative genomics of Neisseria meningitidis strains: new targets for molecular diagnostics

机译:脑膜炎奈瑟菌菌株的比较基因组学:分子诊断的新目标

获取原文
获取原文并翻译 | 示例
           

摘要

In 2010, Jaton et al. (False-negative PCR result due to gene polymorphism: the example of Neisseria meningitidis. J Clin Microbiol 2010; 48: 4590-2) reported an isolate of Neisseria meningitidis serogroup B that was not detected by the ctrA quantitative real-time PCR (qRT-PCR) used in our diagnostic laboratory. Sequence analysis of ctrA revealed several single nucleotide polymorphisms responsible for the negative qRT-PCR. Therefore, we sequenced the genome of this isolate and performed comparative genomics to propose new gene targets for the specific detection of N. meningitidis from clinical specimens. We identified 11 genes as specific to N. meningitidis genomes and common to at least 177 (97%) of the 183 genomes available. Among them, three genes (metA, tauE and shlA) were selected to develop new qRT-PCRs for the detection of N. meningitidis DNA. The three qRT-PCRs were highly sensitive and specific, and they exhibited a good reproducibility when tested on plasmidic positive controls and genomic DNA extracted from strains of N. meningitidis and other relevant bacterial species. The clinical sensitivity and specificity of metA and tauE qRT-PCRs were both 100% based on a testing of cerebrospinal fluid samples positive for N. meningitidis or other clinically relevant bacteria. Despite a 100% specificity, the sensitivity of the shlA qRT-PCR was only 70%. We thus recommend using the metA and/or tauE qRT-PCRs developed here. To prevent PCR failure in the presence of new polymorphic strains, the detection of dual targets by duplex qRT-PCR would be more accurate and suitable for the diagnosis of N. meningitidis from clinical specimens. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
机译:2010年,Jaton等人。 (由于基因多态性导致的假阴性PCR结果:脑膜炎奈瑟氏球菌的例子。JClin Microbiol 2010; 48:4590-2)报告了分离的脑膜炎奈瑟氏菌血清群B,但并未通过ctrA定量实时PCR(qRT)检测到-PCR)用于我们的诊断实验室。 ctrA的序列分析揭示了负责负qRT-PCR的几种单核苷酸多态性。因此,我们对该分离株的基因组进行了测序,并进行了比较基因组学研究,以提出新的基因靶标,用于从临床标本中特异性检测脑膜炎双球菌。我们确定了11种脑膜炎奈瑟氏球菌基因组特有的基因,并且在183个可用基因组中至少有177个(97%)共有。其中,选择了三个基因(metA,tauE和shlA)来开发新的qRT-PCR,以检测脑膜炎双球菌DNA。三种qRT-PCR高度敏感且具有特异性,在质粒阳性对照和从脑膜炎奈瑟氏球菌及其他相关细菌种类中提取的基因组DNA上进行测试时,它们具有良好的可重复性。根据对脑膜炎奈瑟氏球菌或其他临床相关细菌呈阳性的脑脊液样本的检测,metA和tauE qRT-PCR的临床敏感性和特异性均为100%。尽管有100%的特异性,但shlA qRT-PCR的敏感性仅为70%。因此,我们建议使用此处开发的metA和/或tauE qRT-PCR。为了防止在新的多态性菌株存在下PCR失败,通过双工qRT-PCR检测双重靶标将更加准确,适用于从临床标本中诊断脑膜炎双球菌。 (C)2016作者。由Elsevier Ltd代表欧洲临床微生物学和传染病学会出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号